Implantable Cardioverter Defibrillators Market By Type (Transvenous ICDs {Biventricular ICD, Dual-Chamber ICD, and Single-Chamber ICD} and Subcutaneous ICDs), By Application (Sudden Cardiac Arrest (SCA), Ventricular Tachycardia, Heart Failure, and Others), By End-user (Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Nov 2024 | Report ID: MI1423 | 220 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Type

  • Transvenous ICDs
    • Biventricular ICD
    • Dual-Chamber ICD
    • Single-Chamber ICD
  • Subcutaneous ICDs

By Application

  • Sudden Cardiac Arrest (SCA)
  • Ventricular Tachycardia
  • Heart Failure
  • Others

By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Clinics
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Medtronic
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Philips Healthcare
  • St. Jude Medical
  • GE Healthcare
  • Cochlear Limited
  • Dexcom, Inc.
  • Hoya Corporation
  • Smith & Nephew
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • Zoll Medical Corporation
  • Cardinal Health, Inc.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing